T1	CHEM 27 39	pravastatina
#1	AnnotatorNotes T1	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T2	DISO 60 91	neumonía asociada al ventilador
#2	AnnotatorNotes T2	C1701940; Pneumonia, Ventilator-Associated; Disease or Syndrome
T3	PROC 126 136	profilaxis
#3	AnnotatorNotes T3	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T4	PROC 176 183	placebo
#4	AnnotatorNotes T4	C0032042; Placebos; Therapeutic or Preventive Procedure
T5	DISO 207 238	neumonía asociada al ventilador
#5	AnnotatorNotes T5	C1701940; Pneumonia, Ventilator-Associated; Disease or Syndrome
T6	CHEM 501 513	pravastatina
#6	AnnotatorNotes T6	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T7	DISO 540 552	lesión renal
#7	AnnotatorNotes T7	C0160420; Injury of kidney; Injury or Poisoning
T8	PROC 565 572	placebo
#8	AnnotatorNotes T8	C0032042; Placebos; Therapeutic or Preventive Procedure
T9	CHEM 757 769	pravastatina
#9	AnnotatorNotes T9	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T10	PROC 794 801	placebo
#10	AnnotatorNotes T10	C0032042; Placebos; Therapeutic or Preventive Procedure
T11	PROC 878 889	tratamiento
#11	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	CHEM 947 959	pravastatina
#12	AnnotatorNotes T12	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T13	PROC 991 998	placebo
#13	AnnotatorNotes T13	C0032042; Placebos; Therapeutic or Preventive Procedure
T14	DISO 1120 1123	NAV
#14	AnnotatorNotes T14	C1701940; Pneumonia, Ventilator-Associated; Disease or Syndrome
T15	CHEM 1087 1099	pravastatina
#15	AnnotatorNotes T15	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T16	CHEM 1193 1202	estatinas
#16	AnnotatorNotes T16	C0075191; statine; Amino Acid, Peptide, or Protein | C0360714; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Organic Chemical · Pharmacologic Substance
T17	DISO 1240 1248	neumonía
#17	AnnotatorNotes T17	C0032285; Pneumonia; Disease or Syndrome
T18	CHEM 141 153	pravastatina
#18	AnnotatorNotes T18	C0085542; pravastatin; Organic Chemical · Pharmacologic Substance
T19	DISO 240 243	NAV
#19	AnnotatorNotes T19	C1701940; Pneumonia, Ventilator-Associated; Disease or Syndrome
T20	PROC 281 319	ensayo clínico controlado, doble ciego
#20	AnnotatorNotes T20	C0013072; Double-Blind Method; Research Activity + C0681867; Controlled Study; Research Activity
T21	PROC 464 490	asignó de manera aleatoria
#21	AnnotatorNotes T21	C0034656; Randomization; Research Activity
T22	ANAT 547 552	renal
#22	AnnotatorNotes T22	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T23	PROC 596 608	se siguieron
#23	AnnotatorNotes T23	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T24	DISO 636 649	fallecimiento
#24	AnnotatorNotes T24	C1306577; Death (finding); Finding | C1546956; Patient Outcome - Died; Finding
T25	DISO 727 730	NAV
#25	AnnotatorNotes T25	C1701940; Pneumonia, Ventilator-Associated; Disease or Syndrome
T26	PROC 1056 1083	administración profiláctica
#26	AnnotatorNotes T26	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure | C4039267; Administration of prophylactic treatment; Therapeutic or Preventive Procedure
T27	DISO 93 96	NAV
#27	AnnotatorNotes T27	C1701940; Pneumonia, Ventilator-Associated; Disease or Syndrome
T29	Spec_cue 197 206	riesgo de
T30	LIVB 403 412	pacientes
#28	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	Dose 514 519	40 mg
T32	Dose 523 528	10 mg
T33	Duration 617 624	10 días
T35	LIVB 654 662	paciente
#29	AnnotatorNotes T35	C0030705; Patients; Patient or Disabled Group
T36	LIVB 703 712	pacientes
#30	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	LIVB 853 862	pacientes
#31	AnnotatorNotes T37	C0030705; Patients; Patient or Disabled Group
T38	LIVB 922 931	pacientes
#32	AnnotatorNotes T38	C0030705; Patients; Patient or Disabled Group
T41	LIVB 1226 1235	pacientes
#33	AnnotatorNotes T41	C0030705; Patients; Patient or Disabled Group
T42	DEVI 81 91	ventilador
#34	AnnotatorNotes T42	C0087153; Ventilator - respiratory equipment; Medical Device
T43	DEVI 228 238	ventilador
#35	AnnotatorNotes T43	C0087153; Ventilator - respiratory equipment; Medical Device
A1	Assertion T5 Speculated
A2	Assertion T19 Speculated
T28	Neg_cue 1026 1028	No
T34	Observation 1040 1049	beneficio
A3	Assertion T34 Negated
#36	AnnotatorNotes T34	C4049461; Unexpected beneficial therapeutic response; Finding (?)
R1	Negation Arg1:T28 Arg2:T34	
R2	Speculation Arg1:T29 Arg2:T5	
R3	Overlap Arg1:T5 Arg2:T43	
R4	Overlap Arg1:T43 Arg2:T19	
T39	Spec_cue 1162 1169	posible
T40	Observation 1170 1185	efecto benéfico
A4	Assertion T40 Speculated
#37	AnnotatorNotes T40	C4049461;Unexpected beneficial therapeutic response; Finding (?)
R5	Before Arg1:T16 Arg2:T40	
R6	Speculation Arg1:T39 Arg2:T40	
T44	Spec_cue 120 122	si
T45	CONC 184 193	disminuye
A5	Assertion T45 Speculated
#38	AnnotatorNotes T45	C0392756; Reduced; Qualitative Concept
R7	Speculation Arg1:T44 Arg2:T45	
R8	Speculation Arg1:T29 Arg2:T19	
A6	Assertion T3 Speculated
A7	Assertion T18 Speculated
A8	Assertion T4 Speculated
T46	LIVB 869 889	grupo de tratamiento
#39	AnnotatorNotes T46	C5205742; Treatment Group; Population Group
T47	Observation 1 20	Efecto profiláctico
R9	Causes Arg1:T1 Arg2:T47	
R10	Overlap Arg1:T2 Arg2:T42	
R11	Overlap Arg1:T42 Arg2:T27	
R12	Before Arg1:T1 Arg2:T2	
R13	Speculation Arg1:T44 Arg2:T3	
R14	Speculation Arg1:T44 Arg2:T18	
R15	Used_for Arg1:T18 Arg2:T3	
R16	Speculation Arg1:T44 Arg2:T4	
R19	Before Arg1:T21 Arg2:T6	
R20	Before Arg1:T21 Arg2:T8	
R21	Experiences Arg1:T30 Arg2:T8	
R22	Experiences Arg1:T30 Arg2:T6	
R23	Has_Dose_or_Strength Arg1:T6 Arg2:T31	
R24	Has_Dose_or_Strength Arg1:T6 Arg2:T32	
R25	Location_of Arg1:T22 Arg2:T7	
R26	Experiences Arg1:T30 Arg2:T7	
R27	Overlap Arg1:T32 Arg2:T7	
T48	Observation 417 454	cumplieron los criterios de inclusión
#40	AnnotatorNotes T48	C1302261; Patient eligible for clinical trial; Finding (?)
R29	Before Arg1:T48 Arg2:T21	
R30	Has_Duration_or_Interval Arg1:T23 Arg2:T33	
R31	Before Arg1:T23 Arg2:T24	
R32	Experiences Arg1:T35 Arg2:T24	
R33	Experiences Arg1:T36 Arg2:T25	
R34	Before Arg1:T9 Arg2:T25	
R35	Experiences Arg1:T36 Arg2:T9	
R36	Before Arg1:T10 Arg2:T25	
R37	Experiences Arg1:T36 Arg2:T10	
T49	CONC 817 827	mortalidad
#41	AnnotatorNotes T49	C0085556; Hospital Mortality; Qualitative Concept
T50	Quantifier_or_Qualifier 828 834	global
#42	AnnotatorNotes T50	C2348867; Global; Qualitative Concept
R38	Has_Quantifier_or_Qualifier Arg1:T49 Arg2:T50	
R39	Experiences Arg1:T46 Arg2:T11	
R40	Experiences Arg1:T46 Arg2:T12	
R42	Used_for Arg1:T12 Arg2:T11	
R43	Experiences Arg1:T38 Arg2:T13	
R44	Before Arg1:T26 Arg2:T34	
R45	Used_for Arg1:T15 Arg2:T26	
R46	Before Arg1:T26 Arg2:T14	
R47	Experiences Arg1:T41 Arg2:T17	
T51	Quantifier_or_Qualifier 1249 1260	establecida
#43	AnnotatorNotes T51	C0443211; Established; Qualitative Concept
R48	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T51	
R49	Experiences Arg1:T41 Arg2:T16	
R50	Experiences Arg1:T38 Arg2:T11	
T52	CONC 1209 1222	supervivencia
#44	AnnotatorNotes T52	C0220921; survival aspects; Functional Concept
R17	Before Arg1:T1 Arg2:T27	
R18	Before Arg1:T3 Arg2:T5	
R28	Experiences Arg1:T41 Arg2:T40	
A10	Experiencer T30 Patient
A11	Experiencer T35 Patient
A12	Experiencer T36 Patient
A13	Experiencer T37 Patient
A14	Experiencer T46 Patient
A15	Experiencer T38 Patient
A16	Experiencer T41 Patient
